The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Spiegel Robert J. | Director | Grant(A) | 6K | $1.28 | $8K |
| May 20, 2026 | McDonald John F | Director | Grant(A) | 220K | — | $0 |
| May 20, 2026 | Molineaux Susan | Director | Grant(A) | 220K | — | $0 |
| May 20, 2026 | Spiegel Robert J. | Director | Grant(A) | 220K | — | $0 |
| May 20, 2026 | O'Farrell Elizabeth G. | Director | Grant(A) | 220K | — | $0 |
| May 20, 2026 | Bir Dawn Carter | Director | Grant(A) | 220K | — | $0 |
| Apr 13, 2026 | Williams Timothy | EVP and Chief Legal Officer | Grant(A) | 2.5M | — | $0 |
| Mar 31, 2026 | Spiegel Robert J. | Director | Grant(A) | 5K | $1.49 | $8K |
| Mar 25, 2026 | Andrews Patricia S | Director | Grant(A) | 270K | — | $0 |
| Mar 25, 2026 | Chinoporos Constantine | Director | Grant(A) | 270K | — | $0 |
| Feb 18, 2026 | Robertson Michelle | EVP, CHIEF FINANCIAL OFFICER | Sell(S) | 10K | $1.94 | $19K |
| Feb 18, 2026 | Robertson Michelle | EVP, CHIEF FINANCIAL OFFICER | Option exercise(M) | 28K | — | $0 |
| Feb 18, 2026 | Robertson Michelle | EVP, CHIEF FINANCIAL OFFICER | Option exercise(M) | 28K | — | $0 |
| Feb 17, 2026 | Robertson Michelle | EVP, CHIEF FINANCIAL OFFICER | Grant(A) | 1.7M | — | $0 |
| Feb 17, 2026 | Eid Joseph | EVP, R&D; Chief Medical Office | Grant(A) | 2.2M | — | $0 |
| Dec 31, 2025 | Spiegel Robert J. | Director | Grant(A) | 6K | $1.32 | $8K |
| Oct 20, 2025 | ElNawawi Ahmed | EVP, Chief Commercial Officer | Grant(A) | 3.0M | — | $0 |
| Sep 30, 2025 | Spiegel Robert J. | Director | Grant(A) | 6K | $1.37 | $8K |
| Aug 7, 2025 | Semerjian Harout | President and CEO, Director | Grant(A) | 7.0M | — | $0 |
| Aug 7, 2025 | Semerjian Harout | President and CEO, Director | Grant(A) | 4.0M | — | $0 |
| Jun 30, 2025 | Spiegel Robert J. | Director | Grant(A) | 6K | $1.41 | $8K |
| May 21, 2025 | Spiegel Robert J. | Director | Grant(A) | 180K | — | $0 |
| May 21, 2025 | O'Farrell Elizabeth G. | Director | Grant(A) | 180K | — | $0 |
| May 21, 2025 | Molineaux Susan | Director | Grant(A) | 180K | — | $0 |
| May 21, 2025 | McDonald John F | Director | Grant(A) | 180K | — | $0 |
| May 21, 2025 | Lawlis V Bryan | Director | Grant(A) | 180K | — | $0 |
| May 21, 2025 | Bir Dawn Carter | Interim President and CEO, Director | Grant(A) | 180K | — | $0 |
| May 21, 2025 | Aggarwal Gaurav | Director | Grant(A) | 180K | — | $0 |
| May 9, 2025 | Lawlis V Bryan | Director | Buy(P) | 13K | $1.18 | $16K |
| Mar 31, 2025 | Spiegel Robert J. | Director | Grant(A) | 5K | $1.59 | $8K |
| Feb 27, 2025 | Ziegler James | EVP, Chief Commercial Officer | Buy(P) | 100K | $1.60 | $160K |
| Feb 27, 2025 | Scarlett John A | Chairman, President and CEO, Director | Buy(P) | 13K | $1.77 | $22K |
| Feb 27, 2025 | Samuels Scott Alan | EVP, Chief Legal Officer | Buy(P) | 15K | $1.61 | $24K |
| Feb 18, 2025 | Robertson Michelle | EVP, Chief Financial Officer | Grant(A) | 110K | — | $0 |
| Feb 18, 2025 | Robertson Michelle | EVP, Chief Financial Officer | Grant(A) | 656K | — | $0 |
| Feb 18, 2025 | Ziegler James | EVP, Chief Commercial Officer | Grant(A) | 529K | — | $0 |
| Feb 18, 2025 | Ziegler James | EVP, Chief Commercial Officer | Grant(A) | 89K | — | $0 |
| Feb 18, 2025 | Samuels Scott Alan | EVP, Chief Legal Officer | Grant(A) | 104K | — | $0 |
| Feb 18, 2025 | Samuels Scott Alan | EVP, Chief Legal Officer | Grant(A) | 621K | — | $0 |
| Feb 18, 2025 | Scarlett John A | Chairman, President and CEO, Director | Grant(A) | 2.5M | — | $0 |
| Feb 18, 2025 | Scarlett John A | Chairman, President and CEO, Director | Grant(A) | 410K | — | $0 |
| Feb 18, 2025 | Grethlein Andrew J | EVP, Chief Operating Officer | Grant(A) | 140K | — | $0 |
| Feb 18, 2025 | Grethlein Andrew J | EVP, Chief Operating Officer | Grant(A) | 839K | — | $0 |
| Dec 31, 2024 | Spiegel Robert J. | Director | Grant(A) | 2K | $3.54 | $8K |
| Nov 11, 2024 | Eid Joseph | EVP, Research and Development | Grant(A) | 2.5M | — | $0 |
| Sep 30, 2024 | Spiegel Robert J. | Director | Grant(A) | 2K | $4.54 | $8K |
| Sep 9, 2024 | Ziegler James | EVP, Chief Commercial Officer | Grant(A) | 1.6M | — | $0 |
| Jul 8, 2024 | Grethlein Andrew J | EVP, Chief Operating Officer | Sell(S) | 674K | $4.56 | $3.1M |
| Jul 8, 2024 | Grethlein Andrew J | EVP, Chief Operating Officer | Option exercise(M) | 674K | $1.72 | $1.2M |
| Jul 8, 2024 | Grethlein Andrew J | EVP, Chief Operating Officer | Option exercise(M) | 453K | — | $0 |
| Jul 8, 2024 | Grethlein Andrew J | EVP, Chief Operating Officer | Option exercise(M) | 222K | — | $0 |
| Jun 28, 2024 | Spiegel Robert J. | Director | Grant(A) | 2K | $4.24 | $8K |
| Jun 10, 2024 | Kapur Anil | EVP, Corp Strategy & CCO | Option exercise(M) | 422K | $1.06 | $447K |
| Jun 10, 2024 | Kapur Anil | EVP, Corp Strategy & CCO | Sell(S) | 422K | $4.65 | $2.0M |
| Jun 10, 2024 | Kapur Anil | EVP, Corp Strategy & CCO | Option exercise(M) | 422K | — | $0 |
| Jun 10, 2024 | Feller Faye | EVP, Chief Medical Officer | Option exercise(M) | 155K | $1.30 | $202K |
| Jun 10, 2024 | Feller Faye | EVP, Chief Medical Officer | Sell(S) | 288K | $4.63 | $1.3M |
| Jun 10, 2024 | Feller Faye | EVP, Chief Medical Officer | Option exercise(M) | 113K | $1.06 | $119K |
| Jun 10, 2024 | Feller Faye | EVP, Chief Medical Officer | Option exercise(M) | 20K | $1.06 | $21K |
| Jun 10, 2024 | Feller Faye | EVP, Chief Medical Officer | Option exercise(M) | 155K | — | $0 |
| Jun 10, 2024 | Feller Faye | EVP, Chief Medical Officer | Option exercise(M) | 113K | — | $0 |
| Jun 10, 2024 | Feller Faye | EVP, Chief Medical Officer | Option exercise(M) | 20K | — | $0 |
| Jun 6, 2024 | Grethlein Andrew J | EVP, Chief Operating Officer | Grant(A) | 453K | — | $0 |
| Jun 6, 2024 | Feller Faye | EVP, Chief Medical Officer | Grant(A) | 50K | — | $0 |
| Jun 6, 2024 | Feller Faye | EVP, Chief Medical Officer | Grant(A) | 200K | — | $0 |
| Jun 6, 2024 | Robertson Michelle | EVP, Chief Financial Officer | Grant(A) | 250K | — | $0 |
| Jun 6, 2024 | Samuels Scott Alan | EVP, Chief Legal Officer | Grant(A) | 250K | — | $0 |
| Jun 6, 2024 | Scarlett John A | Chairman, President and CEO, Director | Grant(A) | 1.0M | — | $0 |
| Jun 6, 2024 | Kapur Anil | EVP, Corp Strategy & CCO | Grant(A) | 250K | — | $0 |
| Jun 4, 2024 | Scarlett John A | Chairman, President and CEO, Director | Sell(S) | 600K | $4.00 | $2.4M |
| Jun 4, 2024 | Scarlett John A | Chairman, President and CEO, Director | Option exercise(M) | 600K | $2.54 | $1.5M |
| Jun 4, 2024 | Scarlett John A | Chairman, President and CEO, Director | Option exercise(M) | 600K | — | $0 |
| May 15, 2024 | Lawlis V Bryan | Director | Sell(S) | 35K | $3.75 | $131K |
| May 15, 2024 | Lawlis V Bryan | Director | Option exercise(M) | 35K | $1.94 | $68K |
| May 15, 2024 | Lawlis V Bryan | Director | Option exercise(M) | 35K | — | $0 |
| May 9, 2024 | O'Farrell Elizabeth G. | Director | Grant(A) | 180K | — | $0 |
| May 9, 2024 | Lawlis V Bryan | Director | Grant(A) | 180K | — | $0 |
| May 9, 2024 | Bir Dawn Carter | Director | Grant(A) | 180K | — | $0 |
| May 9, 2024 | McDonald John F | Director | Grant(A) | 180K | — | $0 |
| May 9, 2024 | Molineaux Susan | Director | Grant(A) | 180K | — | $0 |
| May 9, 2024 | Spiegel Robert J. | Director | Grant(A) | 180K | — | $0 |
| May 9, 2024 | Aggarwal Gaurav | Director | Grant(A) | 180K | — | $0 |
| Mar 29, 2024 | Spiegel Robert J. | Director | Grant(A) | 2K | $3.30 | $8K |
| Feb 14, 2024 | Scarlett John A | CHAIRMAN, PRESIDENT AND CEO, Director | Grant(A) | 3.0M | — | $0 |
| Feb 14, 2024 | Grethlein Andrew J | EVP, CHIEF OPERATING OFFICER | Grant(A) | 1.2M | — | $0 |
| Feb 14, 2024 | Robertson Michelle | EVP, CHIEF FINANCIAL OFFICER | Grant(A) | 850K | — | $0 |
| Feb 14, 2024 | Samuels Scott Alan | EVP & CHIEF LEGAL OFFICER | Grant(A) | 850K | — | $0 |
| Feb 14, 2024 | Kapur Anil | EVP, CORP STRATEGY & CCO | Grant(A) | 750K | — | $0 |
| Feb 14, 2024 | Feller Faye | EVP, CHIEF MEDICAL OFFICER | Grant(A) | 750K | — | $0 |
| Dec 29, 2023 | Aggarwal Gaurav | Director | Grant(A) | 2K | — | $0 |
| Dec 29, 2023 | Molineaux Susan | Director | Grant(A) | 6K | — | $0 |
| Dec 29, 2023 | Spiegel Robert J. | Director | Grant(A) | 3K | — | $0 |
| Nov 26, 2023 | Aggarwal Gaurav | Director | Grant(A) | 200K | — | $0 |
| Sep 29, 2023 | Spiegel Robert J. | Director | Grant(A) | 3K | — | $0 |
| Sep 29, 2023 | Molineaux Susan | Director | Grant(A) | 6K | — | $0 |
| Sep 25, 2023 | Robertson Michelle | EVP, Chief Financial Officer | Grant(A) | 1.4M | — | $0 |
| Aug 24, 2023 | O'Farrell Elizabeth G. | Director | Buy(P) | 7K | $2.28 | $15K |
| Aug 24, 2023 | O'Farrell Elizabeth G. | Director | Buy(P) | 7K | $2.28 | $15K |
| Aug 15, 2023 | Bloom Olivia Kyusuk | EVP, Chief Financial Officer | Grant(A) | 250K | — | $0 |
| Aug 15, 2023 | Feller Faye | EVP, Chief Medical Officer | Grant(A) | 20K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).